Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Chathika K. Weerasuriya"'
Autor:
Rebecca A. Clark, Chathika K. Weerasuriya, Allison Portnoy, Christinah Mukandavire, Matthew Quaife, Roel Bakker, Danny Scarponi, Rebecca C. Harris, Kirankumar Rade, Sanjay Kumar Mattoo, Dheeraj Tumu, Nicolas A. Menzies, Richard G. White
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background India had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01E and BCG-revaccination have recently completed phase IIb
Externí odkaz:
https://doaj.org/article/05430de248de4732aab7f47b7ed3bd34
Autor:
Sahan Jayawardana, Chathika K. Weerasuriya, Puck T. Pelzer, Janet Seeley, Rebecca C. Harris, Michele Tameris, Dereck Tait, Richard G. White, Miqdad Asaria
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-8 (2022)
Abstract Early trials of novel vaccines against tuberculosis (TB) in adults have suggested substantial protection against TB. However, little is known about the feasibility and affordability of rolling out such vaccines in practice. We conducted expe
Externí odkaz:
https://doaj.org/article/899fbcaa76a740298038b565b349a485
Autor:
Allison Portnoy, Rebecca A. Clark, Matthew Quaife, Chathika K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K. Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C. W. Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G. White, Nicolas A. Menzies
Publikováno v:
PLoS Medicine, Vol 20, Iss 1 (2023)
Background Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-saving
Externí odkaz:
https://doaj.org/article/70a06a30f7fc4f5a9afb35f1b03e77a2
Autor:
Chathika K. Weerasuriya, Rebecca C. Harris, C. Finn McQuaid, Fiammetta Bozzani, Yunzhou Ruan, Renzhong Li, Tao Li, Kirankumar Rade, Raghuram Rao, Ann M. Ginsberg, Gabriela B. Gomez, Richard G. White
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e4076f4ef7874fffbd143dbcb11ae8c2
Autor:
Naomi M Fuller, Christopher F McQuaid, Martin J Harker, Chathika K Weerasuriya, Timothy D McHugh, Gwenan M Knight
Publikováno v:
PLoS Pathogens, Vol 20, Iss 4, p e1011574 (2024)
Drug-resistant tuberculosis (DR-TB) threatens progress in the control of TB. Mathematical models are increasingly being used to guide public health decisions on managing both antimicrobial resistance (AMR) and TB. It is important to consider bacteria
Externí odkaz:
https://doaj.org/article/a3f4e8db79af46dcb8d5113e11415ed6
Autor:
Allison Portnoy, Jean-Louis Arcand, Rebecca A Clark, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G White, Nicolas A Menzies
Publikováno v:
PLoS Medicine, Vol 20, Iss 7, p e1004252 (2023)
BackgroundMost individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may
Externí odkaz:
https://doaj.org/article/c05dd181e1f84e7cb5fd5e5ebc0e3787
Autor:
Rebecca A Clark, Christinah Mukandavire, Allison Portnoy, Chathika K Weerasuriya, Arminder Deol, Danny Scarponi, Andrew Iskauskas, Roel Bakker, Matthew Quaife, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, Raymond C W Hutubessy, Birgitte Giersing, Mark Jit, Rebecca C Harris, Nicolas A Menzies, Richard G White
Publikováno v:
The Lancet Global Health. 11:e546-e555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e05b947c3621fd57f07b1406720f7caa
https://doi.org/10.1016/s2214-109x(23)00045-1
https://doi.org/10.1016/s2214-109x(23)00045-1
Autor:
Rebecca A Clark, Chathika K Weerasuriya, Allison Portnoy, Christinah Mukandavire, Matthew Quaife, Roel Bakker, Danny Scarponi, Rebecca C Harris, Kirankumar Rade, Sanjay Kumar Mattoo, Dheeraj Tumu, Nicolas A Menzies, Richard G White
Publikováno v:
medRxiv
BackgroundIndia had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01Eand BCG-revaccination have recently completed Phase IIb trials and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b05224d18ab4c21b68115321cf6bfe
https://europepmc.org/articles/PMC9980245/
https://europepmc.org/articles/PMC9980245/
Autor:
Allison Portnoy, Jean-Louis Arcand, Rebecca A. Clark, Chathika K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G. White, Nicolas A. Menzies
Most individuals who develop tuberculosis (TB) are working-age adults living in low- and middle-income countries (LMICs). The resulting disability and death impacts economic productivity and burdens health systems. New TB vaccine candidates may reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f6053ba7d3f7e7b1f7c9e561d9294d5
https://doi.org/10.1101/2022.11.23.22282690
https://doi.org/10.1101/2022.11.23.22282690
Autor:
Allison Portnoy, Rebecca A. Clark, Chathika K. Weerasuriya, Christinah Mukandavire, Matthew Quaife, Roel Bakker, Ines Garcia Baena, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G. White, Nicolas A. Menzies
Background: One in two patients developing tuberculosis (TB) in low- and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and ec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b89f182aec056288e6dfecb984850f40
https://doi.org/10.1101/2022.10.29.22281678
https://doi.org/10.1101/2022.10.29.22281678